Rasilez 150 mg
Rasilez 150 mg is a medicine authorised by Swissmedic under authorisation number 58050. The authorisation holder is Future Health Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 June 2007 and the authorisation is limited until 30 September 2026. ATC code C09XA02 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 58050 |
|---|---|
| Name | Rasilez 150 mg |
| Full name | Rasilez 150 mg, Filmtabletten |
| Authorisation holder | Future Health Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09XA02 |
| First authorisation | 29 June 2007 |
| Authorisation validity | 30 September 2026 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Rasilez 150 mg, Filmtabletten | B | 29 June 2007 |
| 2 | Rasilez 300 mg, Filmtabletten | B | 29 June 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09XA02 | 02.07.1. | B |
| 8 | 98 | Tablette(n) | C09XA02 | 02.07.1. | B |
| 5 | 28 | Tablette(n) | C09XA02 | 02.07.1. | B |
| 9 | 98 | Tablette(n) | C09XA02 | 02.07.1. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Rasilez 150 mg authorised in Switzerland?
Yes. Rasilez 150 mg is authorised by Swissmedic under authorisation number 58050, data as of 01 September 2026. The authorisation is limited until 30 September 2026.
Which dispensing category does Rasilez 150 mg have?
Rasilez 150 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Rasilez 150 mg?
The authorisation holder is Future Health Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.